A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...
At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin ...
BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesionsData support further development of BT-001 in solid tumors ...
Belfast News Letter on MSN
Asda marks 20th year anniversary in Northern Ireland by dropping the price of almost 300 locally sourced products
From Saturday 18th October, Asda will introduce a major round of price reductions on locally sourced products in its Northern ...
The word “flavonoids” pops up in many discussions about food and diets but just what are they? Flavonoids (also known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback